chr7-102457519-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000292566.4(ALKBH4):āc.784G>Cā(p.Glu262Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,612,960 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000292566.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALKBH4 | NM_017621.4 | c.784G>C | p.Glu262Gln | missense_variant | 3/3 | ENST00000292566.4 | NP_060091.1 | |
ALKBH4 | XM_005250464.4 | c.565G>C | p.Glu189Gln | missense_variant | 3/3 | XP_005250521.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALKBH4 | ENST00000292566.4 | c.784G>C | p.Glu262Gln | missense_variant | 3/3 | 1 | NM_017621.4 | ENSP00000292566.3 | ||
ALKBH4 | ENST00000490528.1 | n.*564G>C | non_coding_transcript_exon_variant | 3/3 | 2 | ENSP00000420362.1 | ||||
ALKBH4 | ENST00000490528.1 | n.*564G>C | 3_prime_UTR_variant | 3/3 | 2 | ENSP00000420362.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000209 AC: 52AN: 248310Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 134818
GnomAD4 exome AF: 0.000145 AC: 212AN: 1460624Hom.: 2 Cov.: 30 AF XY: 0.000151 AC XY: 110AN XY: 726654
GnomAD4 genome AF: 0.000138 AC: 21AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.784G>C (p.E262Q) alteration is located in exon 3 (coding exon 3) of the ALKBH4 gene. This alteration results from a G to C substitution at nucleotide position 784, causing the glutamic acid (E) at amino acid position 262 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at